Editorial: Molecular targeting of the VHL gene pathway in clear cell kidney cancer

Journal of Urology

Volumn 170, Issue 2 I, 2003, Pages 593-594

  Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGIN B; ELONGIN C; GENE PRODUCT; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; IMATINIB; PLATELET DERIVED GROWTH FACTOR; PROTEIN CUL 2; PROTEIN RBX1; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; HIF1AN PROTEIN, HUMAN; LIGASE; LYMPHOKINE; REPRESSOR PROTEIN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VASCULOTROPIN A; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

CLEAR CELL CARCINOMA; EDITORIAL; GENE MUTATION; GENE TARGETING; HUMAN; KIDNEY CARCINOMA; ONCOCYTOMA; ONCOGENE C KIT; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VHL GENE; VON HIPPEL LINDAU DISEASE; BIOSYNTHESIS; GENETICS; KIDNEY TUMOR; METABOLISM; MUTATION; NOTE;

CARCINOMA, RENAL CELL; ENDOTHELIAL GROWTH FACTORS; GENES, TUMOR SUPPRESSOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; LIGASES; LYMPHOKINES; MUTATION; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0038672688     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000077210.05543.ae     Document Type: Editorial

References (13)

1. Linehan, W. M., Walther, M. M. and Zbar, B.: The genetic basis of cancer of the kidney. Unpublished data
2. Linehan, W. M., Zbar, B. and Klausner, R. D.: Renal carcinoma. In: The Genetic Basis of Human Cancer, 2nd ed. Edited by B. Vogelstein and K. W. Kinzler. New York: McGraw-Hill, 2002
3. Latif, F., Tory, K., Gnarra, J. R., Yao, M., Duh, F.-M., Orcutt, M. L. et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260: 1317, 1993
4. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H. et al: Mutation of the VHL tumour suppressor gene in renal carcinoma. Nat Genet, 7: 85, 1994
5. Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P. et al: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet, 16: 68, 1997
6. Schmidt, L., Junker, K., Weirich, G., Glenn, G., Choyke, P., Lubensky, I. A. et al: Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res, 58: 1719, 1998
7. Schmidt, L., Junker, K., Kinjerski, T., Weirich, G., Neumann, H., Brauch, H. et al: Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene, 18: 2343, 1999
8. Tomlinson, I. P., Alam, N. A., Rowan, A. J., Barclay, E., Jaeger, E. E., Kelsell, D. et al: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet, 30: 406, 2002
9. Nickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L. et al: Mutations in a novel gene cause the Birt-Hogg-Dubé syndrome, a genodermatosis with associated pneumothorax/lung cysts and kidney neoplasia. Cancer Cell, 2: 157, 2002
10. Tyers, M. and Rottapel, R.: VHL: a very hip ligase. Proc Natl Acad Sci USA, 96: 12230, 1999
11. Krek, W.: VHL takes HIF's breath away. Nat Cell Biol, 2: E1-E3, 2000
12. Oh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T. Y., Huang, L. E. et al: Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol, 2: 423, 2000
13. Isaacs, J. S., Jung, Y. J., Mimnaugh, E. G., Martinez, A., Cuttitta, F. and Neckers, L. M.: Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J Biol Chem, 277: 29936, 2002